Company Filing History:
1 out of 73 
1 out of 1,595 
1 out of 17 
Years Active: 2025
Title: The Innovative Contributions of Stacey Van Pelt
Introduction
Stacey Van Pelt is a notable inventor based in Houston, Texas. He has made significant contributions to the field of cancer research through his innovative patent. His work focuses on developing methods and compositions for targeting cancer cells, showcasing his commitment to advancing medical science.
Latest Patents
Stacey Van Pelt holds a patent for "Methods and composition for a binding molecule targeting cancer cells expressing SSX2 peptide 41-49 in HLA-A*0201 context." This patent discloses binding molecules related to Synovial Sarcoma X breakpoint 2 and outlines methods for their use in the detection and treatment of cancer. His research aims to improve cancer diagnostics and therapies, highlighting the importance of targeted treatment options.
Career Highlights
Throughout his career, Stacey has worked with prestigious institutions such as Children's National Medical Center and Washington University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Stacey has collaborated with notable individuals, including Eric Yvon and Catherine M. Bollard. These partnerships have further enhanced his research efforts and expanded the impact of his work in cancer treatment.
Conclusion
Stacey Van Pelt's innovative contributions to cancer research through his patent and collaborations with esteemed institutions and individuals underscore his dedication to improving medical outcomes. His work continues to inspire advancements in the field of oncology.